For most patients, the FDA-approved option is more accessible in 2026 than it has been in years
The used search terms were: "GLP-1 receptor agonist and SGLT2 inhibitor" OR "SGLT2 inhibitor and GLP-1 receptor agonist" OR "SGLT-2 inhibitor and GLP-1 receptor agonist" OR "GLP-1 receptor agonist and SGLT-2 inhibitor" OR "GLP-1 receptor agonists as add-on to SGLT2 inhibitors" OR "GLP1 receptor agonist and SGLT-2 inhibitor" OR "GLP-1 agonist plus SGLT2 inhibitor" OR "glucagon-like peptide-1 receptor agonist and sodium-glucose cotransporter 2 inhibitor" OR "sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist" OR "SGLT2 inhibitors and GLP1-RA" OR "addition of SGLT2i to GLP-1RA" OR "SGLT-2 inhibitor therapy added to GLP-1 agonist therapy" OR "GLP-1 analogues and SGLT-2 inhibitors"
Common factors are dogs of larger body weight or those who are overweight
[17] [18] Berries (blueberries, strawberries, blackberries), dark chocolate (70% cocoa or higher), and extra virgin olive oil are rich in polyphenols with potential metabolic benefits
Therefore, most trials of potential disease modifying medications in early PD follow patients for about 6 months to 1 year
Akin Belli A, Alatas ET, Kara Polat A, Akbaba G
